Investigating A Potential Serum Biomarker For Lung Cancer Closing The Gaps In NSCLC podcast

Контент предоставлен ReachMD. Весь контент подкастов, включая выпуски, графику и описания подкастов, загружается и предоставляется непосредственно ReachMD или его партнером по платформе подкастов. Если вы считаете, что кто-то использует вашу работу, защищенную авторским правом, без вашего разрешения, вы можете выполнить процедуру, описанную здесь https://ru.player.fm/legal.

Closing the Gaps in NSCLC »
Investigating a Potential Serum Biomarker for Lung Cancer

3y ago

MP3•Главная эпизода

Архивные серии ("Канал не активен" status)

When? This feed was archived on August 02, 2022 08:10 (1+ y ago). Last successful fetch was on September 30, 2021 17:36 (2+ y ago)

Why? Канал не активен status. Нашим серверам не удалось получить доступ к каналу подкаста в течении длительного периода времени.

What now? You might be able to find a more up-to-date version using the search function. This series will no longer be checked for updates. If you believe this to be in error, please check if the publisher's feed link below is valid and contact support to request the feed be restored or if you have any other concerns about this.

Host: Paul Doghramji, MD
Guest: Tony Y. Hu, PhD
Since treatment outcomes vary greatly between lung cancer patients—even among those who are diagnosed at the same stages of disease—much research has been devoted to finding biomarkers that identify patients who are most likely to develop metastatic disease. Here to walk us through a promising line of research with hopes of adding the first serum biomarker to the fight against non-small cell lung cancer is Dr. Tony Hu, professor and Weatherhead Presidential chair in Biotechnology Innovation at Tulane University Medical School.

12 эпизодов

#Science #Medicine #ReachMD #Howard (Jack) West #Health and Well-Being